1-14 of 14
Josep M Marti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM)

Camila Guerrero, Noemi Puig, Maria Teresa Cedena Romero, Ibai Goicoechea, Leire Burgos, Diego Alignani, Aitziber Lopez, Sarai Sarvide, María José Calasanz, Ramon Garcia-Sanz, Joaquin Martinez-Lopez, Laura Rosiñol, Esther González Garcia, Albert Oriol, Rafael Rios, Estrella Carrillo-Cruz, Marta Sonia Gonzalez Perez, Carmen Montes Gaisan, Felipe De Arriba, Jose Maria Arguiñano, Josep M Marti, Yolanda Gonzalez-Montes, Antonio Garcia-Guiñon, Juan-José Lahuerta, Joan Bladé Creixenti, Maria-Victoria Mateos, Jesús San-Miguel, Bruno Paiva
Journal: Blood
Blood (2022) 140 (Supplement 1): 246–248.
https://doi.org/10.1182/blood-2022-165402
Published: 2022
Journal Articles

Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Is an Independent Prognostic Factor for Multiple Myeloma and Could Complement Prognosis Value of Minimal Residual Disease

Sunil Lakhwani, Laura Rosinol Dachs, Noemi Puig, Miguel Angel Pico Picos, Laura Medina-González, Joaquín Martínez-López, Bruno Paiva, Albert Oriol, Rafael Rios, María Jesús Blanchard, Isidro Jarque, Joan Bargay, Jose Maria Moraleda, Estrella Carrillo-Cruz, Anna Sureda, Isabel Krsnik, Esther González Garcia, Luis Felipe Casado Montero, Josep M Marti, Cristina Encinas, Felipe De Arriba, Luis Palomera, Antonia Sampol, Yolanda Gonzalez-Montes, Cristina Motllo, Javier De La Cruz, Rafael Alonso Fernández, María-Victoria Mateos, Joan Bladé Creixenti, Juan-José Lahuerta, Jesús San-Miguel, Miguel-Teodoro Hernández
Journal: Blood
Blood (2022) 140 (Supplement 1): 2101–2103.
https://doi.org/10.1182/blood-2022-167247
Published: 2022
Journal Articles

Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial

Laura Rosinol, Albert Oriol, Rafael Ríos Tamayo, María Jesús Blanchard, Isidro Jarque, Joan Bargay, Miguel-Teodoro Hernández, Jose Maria Moraleda, Estrella Carrillo-Cruz, Anna Sureda, Joaquín Martínez-López, Isabel Krsnik, Esther González Garcia, Felipe Casado, Josep M Marti, Cristina Encinas, Felipe De Arriba, Luis Palomera, Antonia Sampol, Yolanda Gonzalez-Montes, Elena Cabezudo, Maria-Victoria Mateos, Jesus San-Miguel, Juan Jose Lahuerta, Joan Bladé Creixenti
Journal: Blood
Blood (2021) 138 (Supplement 1): 466.
https://doi.org/10.1182/blood-2021-146798
Published: 2021
Journal Articles

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

Laura Rosiñol, Albert Oriol, Rafael Rios, Anna Sureda, María Jesús Blanchard, Miguel Teodoro Hernández, Rafael Martínez-Martínez, Jose M. Moraleda, Isidro Jarque, Juan Bargay, Mercedes Gironella, Felipe de Arriba, Luis Palomera, Yolanda González-Montes, Josep M. Martí, Isabel Krsnik, Jose M. Arguiñano, Maria Esther González, Ana Pilar González, Luis Felipe Casado, Lucia López-Anglada, Bruno Paiva, Maria-Victoria Mateos, Jesus F. San Miguel, Juan-José Lahuerta, Joan Bladé
Journal: Blood
Blood (2019) 134 (16): 1337–1345.
https://doi.org/10.1182/blood.2019000241
Published: 2019
Includes: Supplemental data
Journal Articles

Bortezomib, Lenalidomide and Dexamethasone (VRD-GEM) As Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Prospective Phase III Pethema/GEM Trial

Laura Rosinol, MD PhD, Albert Oriol, MD, Rafael Rios, Anna Sureda, MD PhD, M Jesús Blanchard, Miguel T Hernández, Rafael Martínez-Martínez, Jose M Moraleda, Isidro Jarque, Juan Bargay, Mercedes Gironella, Dra., Maria José Moreno, Luis Palomera, Yolanda Gonzalez-Montes, Josep M Marti, Isabel Krsnik, Jose M Arguiñano, Maria Esther González, Ana Pilar González, Felipe Casado, Lucía Lopez-Anglada, Bruno Paiva, PhD, Maria-Victoria Mateos, MD PhD, Jesus F. San Miguel, MD, Juan-José Lahuerta, Joan Blade, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2017.
https://doi.org/10.1182/blood.V130.Suppl_1.2017.2017
Published: 2017
Journal Articles

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Jorge Sierra, Ana Garrido, MD, Susana Vives, MD, Maria Paz Queipo De Llano, Ramon Guàrdia, MD, Marina Diaz-Beyá, Marisa Calabuig, MD, Marta Pratcorona, Montserrat Arnan Sangerman, Olga Salamero, Marta Cervera, MD, Antonia Sampol, MD, Antoni Garcia-Guiñon, Carme Pedro, Josep M Marti, Joan Bargay, MD PhD, Llorenç Font, Josep F Nomdedeu, Montserrat Hoyos, Lourdes Escoda, Montserrat Batlle, Bryan Merchan, Isabel Sanchez-Ortega, Physician, Mar Tormo, MD PhD, David Gallardo, Josep-Maria Ribera, MD, Jordi Esteve, MD, Salut Brunet, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 567.
https://doi.org/10.1182/blood.V130.Suppl_1.567.567
Published: 2017
Journal Articles

The LincRNA HOTAIRM1 , Located in the HOXA genomic Region , impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature

Marina Díaz-Beyá, MD PhD, Alfons Navarro, PhD, Salut Brunet, MD PhD, Josep F Nomdedeu, MD, Anna Cordeiro, Msc, Marta Pratcorona, MD PhD, Meritxell Nomdedeu, MD PhD, Ruth M Risueño, PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MDPhD, Rafael F. Duarte, MD PhD, Olga Salamero, MD, Lourdes Escoda, MD, David Gallardo, MD PhD, Carmen Pedro, MD, Josep M Marti-Tutusaus, Jorge Sierra, MD, Mariano Monzó, MD PhD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1003.
https://doi.org/10.1182/blood.V124.21.1003.1003
Published: 2014
Journal Articles

Feasibility of the AMLprofiler™ (Skyline array) in Patient Risk-Stratification in a Multicenter Trial. Comparison with the Standard Approach

Josep F Nomdedeu, MD, Eulalia Puigdecanet, Elena Bussaglia, PhD, Juan J Hernandez, Maite Carricondo, Camino Estivill, Josep M Marti-Tutusaus, Mar Tormo, Lurdes Zamora, PhD, Josep-Maria Ribera, MD, PhD, Lara Nonell, Anna Aventin, MD, Francesc Sole, Salut Brunet, Jorge Sierra, MD
Journal: Blood
Blood (2012) 120 (21): 4813.
https://doi.org/10.1182/blood.V120.21.4813.4813
Published: 2012
Journal Articles

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Maria Concepcion Garcia-Dabrio, Montserrat Hoyos, Ana Garrido, Salut Brunet, Rafael F Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Jordi Esteve, MD, PhD, Andreu Llorente, Mar Tormo, Ramon Guardia, Natalia Lloveras, Antoni Garcia, Inmaculada Heras, Juan Besalduch, M. Paz Queipo De Llano, MD, Javier Bueno, Joan Bargay, Pio Torres, Josep M. Marti-Tutusaus, Llorenç Font, Anna Aventin, MD, Quentin Lecrevisse, Alberto Orfao, Jorge Sierra, MD, PhD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2012) 120 (21): 1452.
https://doi.org/10.1182/blood.V120.21.1452.1452
Published: 2012
Journal Articles

WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group.

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Camino Estivill, Jordi Esteve, MD, PhD, Mar Tormo, Rafael F Duarte, MD, PhD, Olga Salamero, MD, PAZ Queipo De Llano, MD, Joan Bargay, Inmaculada Heras, Josep M Marti-Tutusaus, Andreu Llorente, Josep-Maria Ribera, MD, PhD, David Gallardo, MD, PhD, Anna Aventin, MD, Salut Brunet, Jorge Sierra, MD
Journal: Blood
Blood (2012) 120 (21): 2524.
https://doi.org/10.1182/blood.V120.21.2524.2524
Published: 2012
Journal Articles

Treatment for Primary Acute Myeloid Leukemia: Results of Two Consecutive Trials From the Spanish CETLAM Group Showing Improvement with the Use of G-CSF Priming and Precise Risk-Adapted Therapy.

Jorge Sierra, MD, Montserrat Hoyos, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Ramon Guardia, Andreu Llorente, Javier Bueno, Juan Besalduch, M. Paz Queipo, Josep M. Marti-Tutusaus, Carmen Pedro, Pio Torres, Antoni Garcia, Inmaculada Heras, Joan Bargay, Llorenç Font, Jose Gonzalez, Antonia Sampol, MD, PhD, Olga Salamero, MD, Lourdes Escoda, David Gallardo, MD, PhD, Marisa Calabuig, Albert Oriol, Montserrat Arnan, Marta Pratcorona, Salut Brunet
Journal: Blood
Blood (2010) 116 (21): 1066.
https://doi.org/10.1182/blood.V116.21.1066.1066
Published: 2010
Journal Articles

Impact of Cytogenetics and New Molecular Markers On the Achievement of Complete Remission in Patients with Primary Acute Myeloid Leukemia. On Behalf of CETLAM Cooperative Group. Spain.

Salut Brunet, Mar Tormo, Jordi Esteve, Josep M. Ribera, Montserrat Hoyos, Josep F. Nomdedeu, Rafael Duarte, Andreu Llorente, Ramon Guardia, M. Paz Queipo de Llano, Joan Besalduch, Inmaculada Heras, Joan Bargay, Carmen Pedro, Josep M. Marti, Javier Bueno, Pio Torres, Dolores Hernandez, Jose Gonzalez, Antoni Garcia, Llorenç Font, Montserrat Arnan, Albert Oriol, David Gallardo, Rosa Goterris, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2009) 114 (22): 4711.
https://doi.org/10.1182/blood.V114.22.4711.4711
Published: 2009
Journal Articles

Use of Granulocyte Colony-Stimulating Factor (G-CSF) Together with Induction and Intensification Chemotherapy (CT) in Adults with Primary Acute Myeloid Leukemia (AML).

Salut Brunet, Granada Perea, Josep M. Ribera, Jordi Esteve, Mar Tormo, Juan Berlanga, Javier Bueno, Andreu Llorente, Jose M. Moraleda, Ramon Guardia, Joan Besalduch, Pio Torres, Maria Paz Queipo de Llano, Josep M. Marti, Carmen Pedro, Joan Bargay, Josep M. Sanchez, Pilar Vivancos, Evaristo Feliu, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2005) 106 (11): 1855.
https://doi.org/10.1182/blood.V106.11.1855.1855
Published: 2005
Journal Articles

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Granada Perea, MD, Adriana Lasa, PhD, Anna Aventin, MD, Alicia Domingo, MD, Neus Villamor, MD, Maria Paz Queipo de LLano, MD, Andreu Llorente, MD, Jordi Junca, MD, Carlos Palacios, MD, Cristalina Fernandez, MD, Miquel Guallart, MD, Llorens Font, MD, Mar Tormo, MD, Lourdes Florensa, MD, Joan Bargay, MD, Josep M. Marti, MD, Pilar Vivancos, MD, Pio Torres, MD, Juan Berlanga, MD, Salut Brunet, MD, Jorge Sierra, MD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2004) 104 (11): 2989.
https://doi.org/10.1182/blood.V104.11.2989.2989
Published: 2004